The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Kite/Gilead
Stock and Other Ownership Interests - Gilead Sciences
Outcomes of patients (pts) treated with prior blinatumomab (Blin) in ZUMA-3: A study of KTE-C19, an anti-CD19 chimeric antigen receptor (CAR) t cell therapy, in adult pts with relapsed/refractory acute lymphoblastic leukemia (R/R ALL).
 
Bijal D. Shah
Consulting or Advisory Role - Adaptive Biotechnologies; Baxalta; Celgene; Pfizer
Research Funding - Incyte; Rosetta Genomics
 
Olalekan O. Oluwole
Consulting or Advisory Role - Kite/Gilead
 
Maria R. Baer
No Relationships to Disclose
 
Michael Russell Bishop
Employment - UnitedHealthcare
Honoraria - Celgene
Consulting or Advisory Role - Seagen
Speakers' Bureau - Celgene; Juno Therapeutics; Novartis
 
Houston Eccleston Holmes
Consulting or Advisory Role - Bayer; Janssen; Rigel
Speakers' Bureau - Kite, a Gilead company; Seagen
Research Funding - Infinity Pharmaceuticals; Juno Therapeutics; Kite/Gilead; Seagen; Unum Therapeutics
Patents, Royalties, Other Intellectual Property - Patent Pending
Travel, Accommodations, Expenses - Bayer; Kite/Gilead
 
Gary J. Schiller
Research Funding - Kite/Gilead
 
William Bruce Donnellan
No Relationships to Disclose
 
Kristen Marie Carr-O'Dwyer
No Relationships to Disclose
 
Armen Mardiros
Employment - Kite/Gilead
Stock and Other Ownership Interests - Gilead Sciences
Patents, Royalties, Other Intellectual Property - MustangBio
 
John M. Rossi
No Relationships to Disclose
 
Tong Shen
Employment - Kite/Gilead
Stock and Other Ownership Interests - Gilead Sciences
 
Allen Xue
Employment - Kite/Gilead
Stock and Other Ownership Interests - Gilead Sciences
 
Rajul K. Jain
Employment - Kite/Gilead
Stock and Other Ownership Interests - Amgen; Gilead Sciences
Patents, Royalties, Other Intellectual Property - Kite, a Gilead company
 
Remus Vezan
Employment - Kite/Gilead
Stock and Other Ownership Interests - Gilead Sciences
 
William G. Wierda
Consulting or Advisory Role - Abbvie; Celgene; Emergent BioSolutions; Genentech/Roche; Genzyme; Gilead Sciences; GlaxoSmithKline/Novartis; Merck; Pharmacyclics; Sanofi
Research Funding - Abbvie; Acerta Pharma; Emergent BioSolutions; Genentech; Gilead Sciences; GlaxoSmithKline/Novartis; Janssen; Juno Therapeutics; Karyopharm Therapeutics; Kite, a Gilead company; Pharmacyclics